Navigation Links
Masimo to Report Second Quarter 2011 Financial Results after Market Close on August 9, 2011
Date:7/19/2011

IRVINE, Calif., July 19, 2011 /PRNewswire/ -- Masimo (NASDAQ: MASI) announced today that it will release second quarter financial results for the period ended July 2, 2011, after the market closes on August  9, 2011.  The release and conference call date is approximately one week later than Masimo's traditional release timing due to executive calendar conflicts during the month of July.  

The conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by Joe Kiani, Chairman and Chief Executive Officer, and Mark P. de Raad, Executive Vice President and Chief Financial Officer.

A live webcast of the conference call will be available online from the investor relations page of the company's corporate web site at www.masimo.com. The dial-in numbers are (888) 520-7182 for domestic callers and +1 (706) 758-3929 for international callers. The reservation code for both dial-in numbers is 78780959.  After the live webcast, the call will be available on Masimo's website through September 9, 2011. In addition, a telephonic replay of the call will be available through August 23, 2011. The replay dial-in numbers are (800) 642-1687 for domestic callers and +1 (706) 645-9291 for international callers. Please use reservation code 78780959.

About MasimoMasimo (NASDAQ: MASI) is the global leader in innovative noninvasive monitoring technologies that significantly improve patient care—helping solve "unsolvable" problems.  In 1995, the company debuted Measure-Through Motion and Low Perfusion pulse oximetry, known as Masimo SET®, which virtually eliminated false alarms and increased pulse oximetry's ability to detect life-threatening events.  More t
'/>"/>

SOURCE Masimo
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. New Research Shows Masimo Perfusion Index (PI) Effective in the Noninvasive Detection of Congenital Heart Defects (CHD) in Newborns
2. New Clinical Studies Presented at the 14th World Congress of Anesthesiology Demonstrate Masimo Advancements in Patient Care
3. New NIH-Funded Study Shows Masimo Rainbow SET(R) May Help Clinicians Assess Oxygenation in Children With Sickle Cell Disease
4. New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring
5. Masimo to Report Third Quarter 2009 Financial Results on November 3, 2009
6. New Clinical Studies Demonstrate the Accuracy of Masimo Noninvasive and Continuous Hemoglobin Monitoring Technology
7. New Published Study Shows Masimo Rainbow SET(R) Pulse CO-Oximetry(TM) Reliably Determines Carbon Monoxide Levels in the Blood
8. CareFusion Signs Multi-Year Technology Licensing Agreement for Masimo Rainbow SET(R) Pulse CO-Oximetry(TM)
9. St.Vincent Hospital Renews Multi-Year, System-wide Contract for Masimo SET(R) Pulse Oximetry Technology
10. Masimo Expands its Irvine, California Corporate Headquarters to Accommodate Growth Projections
11. Masimo to Present at the 28th Annual J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 23, 2013 InspireMD, Inc. ... leader in embolic protection stents, today announced new ... ST Elevation Reperfusion) trial demonstrating that the MGuard ... drug eluting stents in all-cause mortality in ST ... the trial were presented at the InspireMD STEMI ...
(Date:5/23/2013)... Switzerland and DRESDEN, Germany ... Cenix BioScience, a leading preclinical contract research ... and high content-driven pharmacology, and Debiopharm Group™ (Debiopharm), ... a focus on the development of prescription drugs ... companion diagnostics, today announced that they have signed ...
(Date:5/22/2013)... Tenn. , May 22, 2013  Team Health ... of the largest suppliers of outsourced healthcare professional staffing ... in the United States , today ... 38th Annual Deutsche Bank Healthcare Conference held on May ... will begin at 8:00 AM eastern time.  Interested investors ...
Breaking Medicine Technology:InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 3InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 4InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 5Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 2Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 3Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 4Team Health Holdings Inc. to Present at the 38th Annual Deutsche Bank Healthcare Conference 2
... GROVE, Minn., Feb. 18, 2011 Upsher-Smith Laboratories, Inc., ... announced recall of Jantoven® Warfarin Sodium, USP, 3 mg ... the same packaging line between May 17, 2010 and ... as a precautionary measure after a single bottle labeled ...
... Chilcott plc (Nasdaq: WCRX ) today announced that ... is scheduled to speak at the Citi 2011 Global Health ...   The presentation will be simultaneously webcast ... webcast available shortly thereafter at http://ir.wcrx.com/events.cfm . ...
Cached Medicine Technology:Upsher-Smith Laboratories Announces Expansion of Voluntary Nationwide Recall 2Upsher-Smith Laboratories Announces Expansion of Voluntary Nationwide Recall 3
(Date:5/23/2013)... some fast-food chains are required to provide calorie and ... kids who eat fast food at least twice a ... information than kids who eat fast food less often, ... likely to use the calorie information are girls and ... U.S. Centers for Disease Control and Prevention. The ...
(Date:5/23/2013)... Thompson HealthDay Reporter , , THURSDAY, May 23 ... millions to lower their cholesterol, but the medications also ... health through exercise, researchers say. A small group ... any significant fitness gains while taking a 40 milligram ... the drug but undergoing the same exercise regimen did ...
(Date:5/23/2013)... patients with a liposomal formulation of anthracycline-based chemotherapy at ... in high survival rates without causing any added heart ... published online today in Blood ... Hematology (ASH). , Acute myeloid leukemia (AML), ... is a blood cancer in which the bone marrow ...
(Date:5/23/2013)... influences soldier PTSD , Soldiers returning home from ... post-traumatic stress disorder if public support for a war ... or invalidation shapes the level of distress soldiers feel ... study involved two experiments that asked participants to exterminate ... having an actor show either interest or disgust for ...
(Date:5/23/2013)... A new study determined that children and adolescents ... to have clinically significant behavioral problems and psychiatric ... , a journal published by Wiley on behalf ... the importance of routine psychiatric evaluation for pediatric ... to anti-seizure medications and require epilepsy surgery. ...
Breaking Medicine News(10 mins):Health News:Too Few Kids Use Fast-Food Calorie Info, Study Finds 2Health News:Statins May Hamper Workout Results 2Health News:Statins May Hamper Workout Results 3Health News:Improved chemo regimen for childhood leukemia may offer high survival, no added heart toxicity 2Health News:Improved chemo regimen for childhood leukemia may offer high survival, no added heart toxicity 3Health News:Link between war support and PTSD, time it late in negotiations and courtship by narcissists 2Health News:Link between war support and PTSD, time it late in negotiations and courtship by narcissists 3Health News:Depression common among children with temporal lobe epilepsy 2
... Two ... biopharmaceutical environment. , ... Horsham, PA, USA (Vocus) June 5, 2009 -- The Drug Information ... longest running global, multidisciplinary conference featuring sessions and preconference tutorials on issues affecting drug ...
... techniques and bedtime habits may ease insomnia , ... sheep, maybe even taken sleeping pills. You might also ... a better night,s rest. , Chronic insomniacs who took ... about sleep hygiene, relaxation techniques and tips for stilling ...
... 5 Cardinal Health will hold an investor and ... EDT. The sole purpose is to discuss the year-to-date ... Health and CareFusion as standalone entities. , , ... the session and will explain pro forma financials for ...
... and serum lipid levels have improved in Swedish middle-aged ... mental stress, however, have increased significantly. These are the ... of Gothenburg, Sweden. The study is part of ... This study was initiated at the end of the ...
... /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (NASD OTC Bulletin ... the Fifth Annual Noble Financial Equity Conference at 9:15 ... Seminole Hard Rock Hotel in Hollywood, FL. Robert ... give a presentation regarding NeoGenomics, market positioning, financial performance, ...
... , Clearance Opens Door To Multi-Billion Dollar Home Skin ... Palomar Medical Technologies Inc. (Nasdaq: PMTI ), a ... today announced that it has become the first company to ... Food and Drug Administration (FDA) for a new, patented, home ...
Cached Medicine News:Health News:DIA 45th Annual Meeting Features Sessions Highlighting Wyeth v. Levine and Pandemic Influenza 2Health News:DIA 45th Annual Meeting Features Sessions Highlighting Wyeth v. Levine and Pandemic Influenza 3Health News:Can't Sleep? Try Online Therapy 2Health News:Cardinal Health Investor and Analyst Advisory 2Health News:Middle-aged women experience more stress but have lower blood pressure 2Health News:NeoGenomics to Present at Noble Financial's 5th Annual Equity Conference on Monday, June 8th 2Health News:Palomar Receives FDA Over-The-Counter Clearance for a Home Use Wrinkle Removal Laser Device 2Health News:Palomar Receives FDA Over-The-Counter Clearance for a Home Use Wrinkle Removal Laser Device 3Health News:Palomar Receives FDA Over-The-Counter Clearance for a Home Use Wrinkle Removal Laser Device 4
Streptavidin A-Beads are polydisperse 1.8 m paramagnetic particles covalently coupled with streptavidin. The paramagnetic particles remain in solution over extended periods of time. Mixing is require...
... method for isolating antibodies, antigens, lectins, ... affinity binding, while retaining biological activity. ... particles to separate biotinylated molecules from ... Beads from the suspension, an external ...
QuantumPlex is a bead kit for multiple analyte-detection research applications in flow cytometry. The beads may be analyzed with any standard cytometer and do not require the use of specialized softw...
... magnetic beads are 1 ... coupled to a form ... can be useful as ... including mRNA isolation and ...
Medicine Products: